AAPC CPC Exam With Confidence Using Practice Dumps

Omalizumab is a drug reported withHCPCS J2357, and the dose is converted into billable units based on the code’s unit definition. In CPC-style questions,150 mgis commonly represented asJ2357 × 30 units(i.e., 5 mg per unit → 150/5 = 30). Administration is atherapeutic subcutaneous injection, reported with96372(therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular). Vaccine administration codes (90460/90471) are not appropriate because omalizumab is not a vaccine. For diagnosis, the statement includesstatus asthmaticusbut does not specify severity category (mild/moderate/severe persistent). In the options provided,J45.902is the “unspecified asthma with status asthmaticus” concept, whereas J45.52 requires severe persistent asthma with status asthmaticus (not documented). Therefore, the correct pairing is96372 + J2357 × 30 + J45.902. CPC exam tip: match administration code type (therapeutic injection vs immunization) and choose the most specific ICD-10-CM supported by documentation.

Modifier selection for discontinued procedures depends onsettingandhow far the procedure progressed. In the CPT modifier framework,-53(Discontinued Procedure) is used when a physician terminates a procedure due toextenuating circumstances or those that threaten the well-being of the patientafter the procedure has begun. Here, anesthesia was given, the incision was made, and then respiratory distress occurred—clearly a patient safety issue requiring stopping the surgery. That matches modifier-53for the surgeon’s claim. Modifier-74is afacilitymodifier (commonly used by ambulatory surgery centers/hospitals for discontinued outpatient procedures after anesthesia), not the surgeon’s CPT modifier in the typical CPC context. Modifier-47indicates anesthesia by the surgeon, which is not the key fact here and does not represent discontinuation. Modifier-52is for reduced services when a service is partially reduced at the physician’s discretion, not terminated for patient safety. Therefore, the oral surgeon reports21060-53.

C2617 = Implant, sinus, drug-eluting, absorbable